$CORZ

DUCHENE TODD M sold $209K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at an average of $20.95 ($20.75–$22.49, $0.21M total) across 3 trades on 2026-07-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published Jul 29, 2026, 8:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, trade dates, and weighted-average price range, executed under a pre-arranged 10b5-1 plan.

02

Market read

Primarily a sentiment/positioning datapoint for CORZ, with low fundamental implications absent additional news.

03

What to watch

The filing does not state reasons beyond the pre-arranged plan; traders should avoid inferring bearish fundamentals without corroborating news.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-29, covering sales dated 2026-07-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Core Scientific, Inc. (CORZ).

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

Form 4 shows officer DUCHENE TODD M sold 10,000 CORZ shares in open-market trades for about $209,476 under a 10b5-1 plan.

Expected impact

Limited near-term impact expected; any effect is likely sentiment-only and typically fades unless paired with other negative news.

Evidence & confidence

The filing is a disclosed insider transaction with specified sale price range and 10b5-1 pre-arrangement, but it does not introduce new company fundamentals, guidance, or regulatory/legal developments.

Market effects

No sector-level read-across; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales under 10b5-1 can be purely mechanical for liquidity planning, so the signal may be overstated.

Key entities

  • Core Scientific, Inc.

    Subject of the Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who sold 10,000 shares in open-market trades under a 10b5-1 plan.

Related articles

$CORZMedAI 8/10

Core Scientific lands USD$14B AMD AI infrastructure partnership

Core Scientific (CORZ) said it signed a 15-year AI infrastructure partnership with AMD (AMD) covering 529 MW of U.S. capacity, with potential contracted revenue above $14B. AMD can reserve an additional 1,925 MW through Dec. 28, 2028, deploying from 2027. Warrants allow AMD to buy up to 30M CORZ shares at $23.47.

$AMDMed

AMD's Core Scientific deal is bigger than the headline number

Nine months ago, Core Scientific shareholders turned down real money. They rejected a $9 billion buyout offer from CoreWeave, according to CNBC. Shareholders bet the company was worth more standing alone. On Tuesday, that bet started to look prescient. AMD agreed to lease more than 500 megawatts of Core Scientific's U.S. data center capacity, according to a press release from the companies. The stock market did not treat the news as a simple win for either side.